Roman Butler Fullerton & CO Vertex Pharmaceuticals Inc Transaction History

Roman Butler Fullerton & CO

$334 Million
Q3 2024

A detailed history of Roman Butler Fullerton & CO transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Roman Butler Fullerton & CO holds 1,650 shares of VRTX stock, worth $829,042. This represents 0.23% of its overall portfolio holdings.

Number of Shares

1,650

Previous 1,651 0.06%

Holding current value

$829,042

Previous $773,000 0.78%

% of portfolio

0.23%

Previous 0.26%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	SELL	$460.0 - $505.78 $460 - $505	-1 Reduced 0.06%	1,650 $767,000
Q2 2024 Jul 15, 2024	BUY	$392.81 - $485.53 $1,964 - $2,427	5 Added 0.3%	1,651 $773,000
Q1 2024 Apr 29, 2024	BUY	$407.69 - $446.08 $122,714 - $134,270	301 Added 22.38%	1,646 $688,000
Q4 2023 Jan 31, 2024	SELL	$343.0 - $410.68 $1.42 Million - $1.7 Million	-4,142 Reduced 75.49%	1,345 $547,000
Q3 2023 Oct 18, 2023	SELL	$338.18 - $362.46 $138,653 - $148,608	-410 Reduced 6.95%	5,487 $1.91 Million
Q2 2023 Jul 25, 2023	BUY	$314.42 - $351.91 $143,375 - $160,470	456 Added 8.38%	5,897 $2.08 Million
Q1 2023 Apr 27, 2023	SELL	$283.23 - $323.1 $139,349 - $158,965	-492 Reduced 8.29%	5,441 $1.71 Million
Q4 2022 Jan 23, 2023	SELL	$285.76 - $321.48 $20,574 - $23,146	-72 Reduced 1.2%	5,933 $0
Q3 2022 Oct 17, 2022	SELL	$273.83 - $305.53 $164,845 - $183,929	-602 Reduced 9.11%	6,005 $1.77 Million
Q2 2022 Jul 26, 2022	BUY	$234.96 - $292.55 $1.24 Million - $1.54 Million	5,277 Added 396.77%	6,607 $1.94 Million
Q1 2022 May 05, 2022	BUY	$221.42 - $260.97 $294,488 - $347,090	1,330 New	1,330 $347,000
Q3 2021 Nov 10, 2021	SELL	$181.39 - $202.99 $214,947 - $240,543	-1,185 Closed	0 $0
Q2 2021 Jul 29, 2021	BUY	$187.49 - $221.1 $41,810 - $49,305	223 Added 23.18%	1,185 $239,000
Q1 2021 Apr 22, 2021	BUY	$207.02 - $241.31 $199,153 - $232,140	962 New	962 $213,000
Q4 2020 Feb 01, 2021	SELL	$207.01 - $276.09 $829,696 - $1.11 Million	-4,008 Closed	0 $0
Q3 2020 Oct 15, 2020	SELL	$255.65 - $303.1 $86,154 - $102,144	-337 Reduced 7.76%	4,008 $1.09 Million
Q2 2020 Jul 28, 2020	BUY	$225.48 - $295.8 $8,568 - $11,240	38 Added 0.88%	4,345 $1.26 Million
Q1 2020 Apr 13, 2020	BUY	$199.77 - $247.81 $435,698 - $540,473	2,181 Added 102.59%	4,307 $1.03 Million
Q4 2019 Jan 27, 2020	BUY	$166.71 - $223.91 $354,425 - $476,032	2,126 New	2,126 $465,000
Q1 2019 Apr 24, 2019	SELL	$163.73 - $194.7 $393,770 - $468,253	-2,405 Closed	0 $0
Q4 2018 Feb 04, 2019	BUY	$151.91 - $192.21 $365,343 - $462,265	2,405 New	2,405 $447,000

Others Institutions Holding VRTX

# of Institutions

1,716

Shares Held

225M

Call Options Held

1.19M

Put Options Held

1.56M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Roman Butler Fullerton & CO, based on Form 13F filings with the SEC.

News

Stay updated on Roman Butler Fullerton & CO with notifications on news.

Account

Roman Butler Fullerton & CO Vertex Pharmaceuticals Inc Transaction History